نتائج البحث

1

Avelumab as second-line therapy for metastatic, platinum-treated urothelial carcinoma in the phase Ib JAVELIN Solid Tumor study: 2-year updated efficacy and safety analysis

المؤلفون: Jeffrey R. Infante, Patrick Schöffski, Michael S. Gordon, Alain Ravaud, Manish Agrawal, John Allan Ellerton, Juliane Manitz, Manish R. Patel, Mary Ruisi, Andrea B. Apolo, Matthew H. Taylor, Luc Dirix, Ding Wang, Keun Wook Lee, Raid Aljumaily, Gregory Pennock, Theodore Gourdin, J.L. Gulley

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, Cancer Research, medicine.medical_specialty, Metastatic Urothelial Carcinoma, Immunology, Antibodies, Monoclonal, Humanized, Gastroenterology, B7-H1 Antigen, programmed cell death 1 receptor, Avelumab, 03 medical and health sciences, 0302 clinical medicine, Internal medicine, Programmed cell death 1, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Medicine, Humans, Until Disease Progression, Solid tumor, RC254-282, Urothelial carcinoma, Aged, Platinum, Pharmacology, Aged, 80 and over, Clinical/Translational Cancer Immunotherapy, Second-line therapy, Carcinoma, Transitional Cell, biology, clinical trials as topic, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Middle Aged, 030104 developmental biology, Oncology, 030220 oncology & carcinogenesis, Toxicity, biology.protein, Molecular Medicine, Female, business, urinary bladder neoplasms, medicine.drug

وصف الملف: Print

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3b5b9fa96546aac04d870e76ec58182cTest
https://jitc.bmj.com/content/8/2/e001246.fullTest

2

Clinicopathological characteristics and management of colitis with anti-PD1 immunotherapy alone or in combination with ipilimumab

المؤلفون: Stephen Tattersall, Serigne Lo, Richard A. Scolyer, K. Nahar, Neomal S. Sandanayake, Alexander M. Menzies, Christopher J. Kiely, Georgina V. Long, Robert V. Rawson, Umaimainthan Palendira, Matteo S. Carlino, Tasnia Ahmed

المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)

مصطلحات موضوعية: 0301 basic medicine, Adult, Male, CTLA-4 antigen, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Immunology, Programmed Cell Death 1 Receptor, Ipilimumab, Gastroenterology, 03 medical and health sciences, 0302 clinical medicine, Antineoplastic Agents, Immunological, Internal medicine, medicine, Immunology and Allergy, Humans, Colitis, Adverse effect, RC254-282, Aged, Pharmacology, Aged, 80 and over, Clinical/Translational Cancer Immunotherapy, biology, business.industry, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunosuppression, Immunotherapy, Middle Aged, medicine.disease, Discontinuation, 030104 developmental biology, Oncology, inflammation, 030220 oncology & carcinogenesis, Toxicity, biology.protein, Molecular Medicine, Female, immunotherapy, Antibody, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6e18204b5d2a77547300ac64b5b8f892Test
https://pubmed.ncbi.nlm.nih.gov/33234603Test

3

Phase II study of atezolizumab in combination with bevacizumab in patients with advanced cervical cancer

المؤلفون: Elad Sharon, Alexandre Buckley de Meritens, Carol Aghajanian, Susan C. Modesitt, Siqing Fu, Bradley R. Corr, Alexia Iasonos, Alexandra Snyder Charen, Dmitriy Zamarin, Michael A. Carducci, Panagiotis A. Konstantinopoulos, Travis J. Hollmann, Qin Zhou, Claire F. Friedman, Jason A. Konner

المصدر: Journal for Immunotherapy of Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Cancer Research, medicine.medical_specialty, Bevacizumab, medicine.medical_treatment, Immunology, Population, Phases of clinical research, Uterine Cervical Neoplasms, Pembrolizumab, Antibodies, Monoclonal, Humanized, programmed cell death 1 receptor, 03 medical and health sciences, 0302 clinical medicine, Atezolizumab, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Immunology and Allergy, Humans, education, Pharmacology, Cervical cancer, Clinical/Translational Cancer Immunotherapy, combination, education.field_of_study, Chemotherapy, business.industry, Middle Aged, medicine.disease, drug therapy, 030104 developmental biology, female, Response Evaluation Criteria in Solid Tumors, 030220 oncology & carcinogenesis, tumor biomarkers, genital neoplasms, Molecular Medicine, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa8224f731a5ceb298b098c2d77cf649Test
https://pubmed.ncbi.nlm.nih.gov/33004542Test

4

Efficacy and immune-related adverse event associations in avelumab-treated patients

المؤلفون: Isabell Speit, Sandra P. D'Angelo, Karen Kelly, Marcis Bajars, Vijay Kasturi, Arun Rajan, Juliane Manitz, Manish R. Patel, James L. Gulley, Andrea B. Apolo, John Warth

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, Cancer Research, medicine.medical_specialty, Drug-Related Side Effects and Adverse Reactions, Immune checkpoint inhibitors, medicine.medical_treatment, Immunology, Improved survival, biostatistics, Antibodies, Monoclonal, Humanized, programmed cell death 1 receptor, Avelumab, 03 medical and health sciences, Young Adult, 0302 clinical medicine, Immune system, Antineoplastic Agents, Immunological, Internal medicine, medicine, Immunology and Allergy, Humans, Adverse effect, RC254-282, Aged, Pharmacology, Aged, 80 and over, Clinical/Translational Cancer Immunotherapy, business.industry, Proportional hazards model, Confounding, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunotherapy, Middle Aged, 030104 developmental biology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, immunotherapy, business, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8f3df9809ae6ddcc1d0ceaf44360b85cTest
https://jitc.bmj.com/content/8/2/e001427.fullTest

5

Reintroduction of immune-checkpoint inhibitors after immune-related meningitis: a case series of melanoma patients

المؤلفون: Stefania Cuzzubbo, Barouyr Baroudjian, P. Tetu, Sarah Guégan, Renata Ursu, Catherine Belin, Céleste Lebbé, C. Lheure, Julie Mazoyer, Lila Sirven Villaros, Antoine F. Carpentier

المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 8, Iss 2 (2020)

مصطلحات موضوعية: Adult, Male, CTLA-4 antigen, Cancer Research, medicine.medical_specialty, medicine.medical_treatment, Immunology, programmed cell death 1 receptor, 03 medical and health sciences, 0302 clinical medicine, Cerebrospinal fluid, Immune system, Prednisone, Internal medicine, medicine, melanoma, Immunology and Allergy, Cytotoxic T cell, Humans, Meningitis, Adverse effect, Immune Checkpoint Inhibitors, RC254-282, Aged, Pharmacology, Clinical/Translational Cancer Immunotherapy, business.industry, Melanoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunotherapy, Middle Aged, medicine.disease, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, immunotherapy, business, 030217 neurology & neurosurgery, medicine.drug

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5785e8d88f96465af3dba28222de387aTest
https://pubmed.ncbi.nlm.nih.gov/32747471Test

6

Propensity score–weighted analysis of chemotherapy after PD-1 inhibitors versus chemotherapy alone in patients with non–small cell lung cancer (WJOG10217L)

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Male, Oncology, Cancer Research, Lung Neoplasms, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Docetaxel, Kaplan-Meier Estimate, chemotherapy, non–small cell lung cancer, 0302 clinical medicine, Carcinoma, Non-Small-Cell Lung, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, 030212 general & internal medicine, Immune Checkpoint Inhibitors, RC254-282, Clinical/Translational Cancer Immunotherapy, Aged, 80 and over, response, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Drug Synergism, Middle Aged, Progression-Free Survival, Drug Combinations, Pemetrexed, 030220 oncology & carcinogenesis, Cohort, Molecular Medicine, Female, PD-1 inhibitors, Cohort study, medicine.drug, Adult, medicine.medical_specialty, Immunology, Antibodies, Monoclonal, Humanized, Ramucirumab, 03 medical and health sciences, Internal medicine, medicine, Humans, Propensity Score, Lung cancer, Aged, Retrospective Studies, Tegafur, Pharmacology, Chemotherapy, business.industry, medicine.disease, Oxonic Acid, Propensity score matching, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::bba83574bb219c567e6e85aee8eba114Test
https://jitc.bmj.com/content/8Test/1/e000350.full

7

Combination anti-PD1 and ipilimumab therapy in patients with advanced melanoma and pre-existing autoimmune disorders

المؤلفون: Alexander Menzies, Prachi Bhave, Alison Weppler, Lauren Julia Brown, Georgina V. Long, Douglas B. Johnson, Clara Allayous, Shahneen Sandhu, Andrew Haydon, Patrick A. Ott, J. Randall Patrinely, Matteo S. Carlino, Céleste Lebbé

المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 9, Iss 5 (2021)

مصطلحات موضوعية: Male, Cancer Research, Skin Neoplasms, Time Factors, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Autoimmunity, Pembrolizumab, Inflammatory bowel disease, 0302 clinical medicine, Antineoplastic Combined Chemotherapy Protocols, Immunology and Allergy, Medicine, 030212 general & internal medicine, Immune Checkpoint Inhibitors, RC254-282, Clinical/Translational Cancer Immunotherapy, Aged, 80 and over, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Immunosuppression, Middle Aged, Progression-Free Survival, Nivolumab, Oncology, 030220 oncology & carcinogenesis, Molecular Medicine, Female, immunotherapy, Immunosuppressive Agents, medicine.drug, CTLA-4 antigen, Adult, medicine.medical_specialty, Combination therapy, Immunology, Ipilimumab, Antibodies, Monoclonal, Humanized, Autoimmune Diseases, Young Adult, 03 medical and health sciences, Internal medicine, melanoma, Humans, Progression-free survival, Aged, Retrospective Studies, Pharmacology, Autoimmune disease, business.industry, medicine.disease, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2f2d951c799ac374f6affd11324d9fbbTest
https://doi.org/10.1136/jitc-2020-002121Test

8

Interferon gamma inhibits CXCL8–CXCR2 axis mediated tumor-associated macrophages tumor trafficking and enhances anti-PD1 efficacy in pancreatic cancer

المؤلفون: Guoping Ding, Neng Lou, Liping Cao, Xu Sun, Tao Shen, Qiang Yan, Xiaodong Xu, Guoliang Cao, Lifeng Huang, Mingjie Zhang, Qiang Wei, Huilian Huang

المصدر: Journal for ImmunoTherapy of Cancer, Vol 8, Iss 1 (2020)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: Male, 0301 basic medicine, Cancer Research, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Kaplan-Meier Estimate, Receptors, Interleukin-8B, Metastasis, 0302 clinical medicine, Cancer immunotherapy, Cell Movement, Antineoplastic Combined Chemotherapy Protocols, Tumor-Associated Macrophages, Tumor Microenvironment, Immunology and Allergy, Interferon gamma, Immune Checkpoint Inhibitors, RC254-282, Clinical/Translational Cancer Immunotherapy, Aged, 80 and over, CD68, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, pancreatic cancer (PC), Drug Synergism, Immunosuppression, Middle Aged, Recombinant Proteins, macrophages, Gene Expression Regulation, Neoplastic, Cytokine, Oncology, 030220 oncology & carcinogenesis, CXCL8, Molecular Medicine, Female, Signal Transduction, medicine.drug, Adult, musculoskeletal diseases, programmed death 1 (PD1), Immunology, Antigens, Differentiation, Myelomonocytic, interferon-gamma (IFN-γ), Interferon-gamma, 03 medical and health sciences, Pancreatectomy, Antigens, CD, Cell Line, Tumor, Pancreatic cancer, medicine, Humans, Interleukin 8, Pancreas, Aged, Pharmacology, CXCR2, cancer immunotherapy, business.industry, Interleukin-8, medicine.disease, Xenograft Model Antitumor Assays, Pancreatic Neoplasms, 030104 developmental biology, Cancer research, Tumor Escape, business

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b9add92f080e2c426b2a829a02b123dfTest
https://doi.org/10.1136/jitc-2019-000308Test

9

Immune induction strategies to enhance responses to PD-1 blockade: lessons from the TONIC trial

المؤلفون: Sandra Demaria, Silvia C. Formenti, Muriel Brackstone, Emanuela Romano

المصدر: Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-4 (2019)
Journal for Immunotherapy of Cancer

مصطلحات موضوعية: 0301 basic medicine, Oncology, Cancer Research, medicine.medical_treatment, Programmed Cell Death 1 Receptor, Triple Negative Breast Neoplasms, B7-H1 Antigen, 0302 clinical medicine, Antineoplastic Agents, Immunological, Tumor Microenvironment, Immunology and Allergy, Neoplasm Metastasis, Triple-negative breast cancer, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Combined Modality Therapy, 3. Good health, Immunogenic cell death, tumor burden, Nivolumab, 030220 oncology & carcinogenesis, Molecular Medicine, Female, Immunotherapy, medicine.drug, Adult, medicine.medical_specialty, Cyclophosphamide, Immunology, Breast Neoplasms, lcsh:RC254-282, Immunomodulation, 03 medical and health sciences, Immune system, Internal medicine, medicine, Humans, Doxorubicin, Aged, Pharmacology, Cisplatin, business.industry, Tumor-infiltrating T cells, Blockade, Radiation therapy, 030104 developmental biology, Concomitant, Commentary, Radiotherapy, Adjuvant, business, T-Lymphocytes, Cytotoxic

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3cc449295f6390e051c7848cff7a10b2Test
https://pubmed.ncbi.nlm.nih.gov/31086347Test

10

Different role of circulating myeloid-derived suppressor cells in patients with multiple myeloma undergoing autologous stem cell transplantation

المؤلفون: Young-Woo Jeon, Tae Woo Kim, Sung-Soo Park, Seok Lee, Hee-Je Kim, Sung-Eun Lee, Da-Bin Ryu, Jae-Ho Yoon, Seok-Goo Cho, Chang-Ki Min, Ji-Young Lim, Dong-Wook Kim, Yoo-Jin Kim, Ki-Seong Eom, Byung-Sik Cho, Jong Wook Lee

المصدر: Journal for Immunotherapy of Cancer
Journal for ImmunoTherapy of Cancer, Vol 7, Iss 1, Pp 1-13 (2019)

مصطلحات موضوعية: 0301 basic medicine, Melphalan, Adult, Male, Cancer Research, Immunology, Context (language use), Autologous stem cell transplantation, lcsh:RC254-282, Transplantation, Autologous, Colony-stimulating factor 1 receptor, Transcriptome, 03 medical and health sciences, 0302 clinical medicine, Autologous stem-cell transplantation, Multiple myeloma, medicine, Immunology and Allergy, Cytotoxic T cell, Humans, Antineoplastic Agents, Alkylating, Aged, Pharmacology, business.industry, Myeloid-Derived Suppressor Cells, Middle Aged, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, Natural killer T cell, medicine.disease, 030104 developmental biology, Oncology, Receptors, Granulocyte-Macrophage Colony-Stimulating Factor, 030220 oncology & carcinogenesis, Myeloid-derived Suppressor Cell, Cancer research, Molecular Medicine, Female, business, medicine.drug, Research Article, Stem Cell Transplantation

الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fa1bdac42beda9a1fdd6c68c33cbee2fTest
http://europepmc.org/articles/PMC6367772Test

تنقيح النتائج